Alnylam Pharmaceuticals, Inc.ALNYNASDAQ
Loading
Income Quality Over TimeExpanding
Percentile Rank100
3Y CAGR+51.7%
5Y CAGR+18.4%
Year-over-Year Change
Quality of reported income
3Y CAGR
+51.7%/yr
vs -10.3%/yr prior
5Y CAGR
+18.4%/yr
Recent acceleration
Acceleration
+62.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.67 | +5489.9% |
| 2024 | 0.03 | +112.6% |
| 2023 | -0.24 | -149.4% |
| 2022 | 0.48 | -36.4% |
| 2021 | 0.75 | +5.0% |
| 2020 | 0.72 | +128.0% |
| 2019 | 0.31 | -57.5% |
| 2018 | 0.74 | -5.3% |
| 2017 | 0.78 | +3.9% |
| 2016 | 0.75 | - |